Dialysis industry news

Stories from the dialysis comunity across the globe.



Zacks Rating on Rockwell Medical, Inc. - American Trade Journal PDF Print

As much as 4 analysts have advised buy on Rockwell Medical, Inc. (NASDAQ:RMTI) with an average broker rating of 2. Research Analysts at Zacks has the shares a rating of 3, which implies that the firms recommendation is Neutral on the company.

Rockwell Medical, Inc. (NASDAQ:RMTI) stock has received a short term price target of $ 16.25 from 4 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $9.18. The higher estimate of target price is $26 , while the lower price target estimate is $4 Currently the company Insiders own 5.5% of Rockwell Medical, Inc. Company shares. In the past six months, there is a change of 0% in the total insider ownership. Institutional Investors own 33.9% of Company shares. During last 3 month period, 24.07% of total institutional ownership has changed in the company shares. Rockwell Medical, Inc. (NASDAQ:RMTI) : On Monday heightened volatility was witnessed in Rockwell Medical, Inc. (NASDAQ:RMTI) which led to swings in the share price. The shares opened for trading at $16.06 and hit $16.6 on the upside , eventually ending the session at $16.51, with a gain of 1.85% or 0.3 points. The heightened volatility saw the trading volume jump to 730,082 shares. The 52-week high of the share price is $18.04 and the company has a market cap of $828 million. The 52-week low of the share price is at $8.095 . The company shares have rallied 36.33% from its 1 Year high price. On Jun 25, 2015, the shares registered one year high at $18.04 and the one year low was seen on Dec 15, 2014. The 50-Day Moving Average price is $12.87 and the 200 Day Moving Average price is recorded at $10.97. Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia, Latin America and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease (ESRD). ESRD is an advanced-stage of chronic kidney disease (CKD) characterized by the irreversible loss of kidney function. Its dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patients bloodstream. As of December 31, 2011, it was licensed and was developing renal drug therapies. During the year ended December 31, 2011, it acquired an abbreviated new drug application (ANDA) for a generic version of an intravenous Vitamin-D analogue, calcitriol.

...

 
NELCDC announces grand opening for U.S. Renal Care at Parkway Place - LubbockOnline.com PDF Print

U.S. Renal Care hosted a grand opening at its new facility at the Parkway Place Plaza on Tuesday.

Parkway Place Plaza is located at 1826 Parkway Drive in East Lubbock and is partly managed by the North & East Lubbock Community Development Corporation.

According to a news release, U.S. Renal Care executed a 10-year lease at the beginning of 2015. Care providers at the new dialysis center began seeing its first patients on May 4. They currently only serve patients with private insurance providers, but are seeking approval to accept Medicare patients, according to the news release.

...

 
Risk Factors for CKD Progression ID'd - Renal and Urology News PDF Print
July 07, 2015 Risk Factors for CKD Progression ID'd - Renal and Urology News
Proteinuria, hyperphosphatemia, anemia linked more rapid annual decline in eGFR.

Proteinuria, high blood pressure, and anemiaare major risk factors for chronic kidney disease (CKD) progression, a new Japanese study confirms.

In addition, hyperphosphatemia and hyperuricemia—which are other time-dependent factors that change with the natural course of CKD and treatment—emerged as important potential targets for clinical intervention.

For the retrospective study, investigators led by Shunya Uchida, MD, of Teikyo University in Tokyo, calculated the yearly decline in estimated glomerular filtration rate (eGFR) for 770 male and female patients with CKD stages 3 or 4 and correlated eGFR with follow-up laboratory results taken every 1–3 months for an average of 4 years (prior to dialysis initiation). The researchers looked at a host of blood and urinary parameters, such as hemoglobin, albumin, nitrogen, creatinine, hematuria, uric acid, sodium, potassium, phosphate, low-density lipoprotein cholesterol, and C-reactive protein.

According to results published online in Clinical and Experimental Nephrology, risk factors strongly associated with more rapid decline in eGFR included proteinuria, hyperphosphatemia, and anemia, suggesting these factors could be targets for intervention. Older age, lower albumin, and higher hemoglobin appeared to be protective.

The investigators speculated that higher phosphorus levels and subsequent calcium deposits may contribute to arterial sclerosis.

The study also found that men with CKD experience more rapid decline in kidney function than women (average eGFR decline 2.83 vs. 1.66 mL/min/1.73 m2 per year).

Limitations of the study included lack of information about medication usage (other than antihypertensive drugs), genetic factors, and parameters related to CKD mineral bone disease.

 

Source

Chang, W, et al. Clin Exp Nephrol, June 2015; doi: 10.1007/s10157-015-1132-0.

http://link.springer.com/article/10.1007%2Fs10157-015-1132-0

...

 
Couple wants to bring smiles to dialysis patients - Times of Fort Erie PDF Print

Jack Wilson thought he was tired from working too hard.

He never suspected that he might be sick.

“He went to the doctor in December 2013. Jack was 50 years old when he was diagnosed with chronic kidney disease,” said his wife, Earlene. “He was already at the point of needing a transplant.”

Doctors also discovered Jack had cancer in his left kidney and removed it, leaving him with one low-functioning kidney.

While he waits for a kidney transplant, Jack's life now depends on a large machine made for home hemodialysis, an artificial kidney that cleans his blood of waste and excess fluid.

Every other day, Jack sits in a leather recliner in a bedroom of his home, facing a flat-screen television while he is connected to the life-saving machine that cleans his blood.

“Being so young, it was suggested to us by hospital staff that Jack would be a good candidate for home dialysis,” Earlene said.

Jack receives dialysis every other day, beginning early in the morning and lasting about five hours.

Earlene said preparing the machine for Jack's treatment and hooking him up to the machine can take anywhere from 30 to 40 minutes depending on how organized she.

The Wilsons said they weren't aware home dialysis was an option. But it made sense for them because Jack could receive his treatments in the comfort of his own home.

“Jack is dependent on the machine. For us that would have meant every other day in the hospital.”

The couple admits they “were leery about home dialysis at first” because there was a lot to learn about the process.

“I have to insert all of Jack's needles into his arm before each treatment,” Earlene said.

The Niagara Health System provided the Wilsons with everything they need including supplies, equipment and the installation of a water purification system so Jack can receive his dialysis at home.

They also received seven weeks of training and have access to a 24-hour hotline to call if there are any problems or concerns during his dialysis treatments.

Jack said home dialysis has become easier thanks to support from NHS staff and his wife, Earlene.

“It's like riding a bicycle. Once you know how to do it, you just know how to do it,” he said.

“My wife is also a saint,” he added.

Earlene is always nearby in case Jack needs assistance.

She works full-time at the Stevensville Garden Gallery in addition to assisting Jack with his treatment. It hasn't been an easy road for the Wilsons but they are managing to make ends meet.

The Wilsons were looking forward to retirement and spending their golden years together until Jack got sick. Their children had left home and they had purchased their dream home, a farm on Bowen Road.

“We had to sell our farm when Jack got sick. The farm wasn't connected to city water and city sewers so we had to move and downsize.”

The Wilsons went from a dual-income family to living on just one income, a smaller home, one car and increased bills.

“We definitely struggled with all of the medical expensive. Jack has five drugs that we have to pay for that aren't covered by insurance,” Earlene said.

“Our water and hydro bills doubled because of the cost of running Jack's home dialysis.”

The Wilsons know their story is “similar to many other people” and that's why they want to help other families who are currently receiving home dialysis treatments.

“We want to help people,” Earlene said. “Even though we are at home, there are still costs involved. We have to make monthly trips to the hospital in Hamilton and that's at least a $50 day for gas and parking. That doesn't even include a meal.”

All those “extra expenses add up,” making a tight budget even tighter. But Earlene said she is grateful that Jack is able to receive his treatment at home.

“We believe in this program and if we had a choice to do it all over again, we would make the same decision.”

The Wilsons have created a charity called Bringing Chronic Smiles. All of the proceeds are donated to patients who have Chronic Kidney Disease.

The Wilsons held a garage sale last month and raised $800 in one day.

“With that money, we purchased grocery store and gas gift cards which will be given to home dialysis patients,” Earlene said.

Peggi Garner, a nurse with the Niagara Health System, taught the Wilsons how to do home dialysis. She has also been charged with the task of delivering the gift cards that were purchased with funds raised through Bringing Chronic Smiles to recipients.

“What inspires me about these two is that they took their own experiences and the reality of their struggles and turned it around,” Garner said.

For more information about Bringing Chronic Smiles visit www.bringingchronicsmiles.myevent.com. Donation boxes are also available at the Stevensville Garden Gallery, 2821 Stevensville Rd., in Stevensville.

Garner said she respects the Wilsons and their commitment to “ease the burden of home dialysis” for other families.

There are about 20 patients in Niagara that are currently receiving home hemodialysis in Niagara as part of the Kidney Care Program, said Cindy Bryson, clinical manager of outpatient kidney care program at the St. Catharines hospital.

“We’re trying to increase those numbers because it’s a lot better for patients’ outcomes so they don’t have to come to a hospital setting.”

The goal of the program to help patients live as “autonomously and independently” as they can by helping them takes control over the management of their disease.

In order to make patients more comfortable with the home treatment, Bryson said the NHS provides patients with training and all of the necessary equipment to do their dialysis at home. The program allows patients to learn more about their disease and take control of it.

For more information about the Kidney Care Program call Phone: 905.378.4647 ext. 43131.

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Who: Jack and Earlene Wilson

What: The Stevensville residents want to help other families who have a loved one receiving home dialysis treatments.

Where: Donations can be dropped off at the Stevensville Garden Gallery, Stevensville Garden Gallery, 2821 Stevensville Rd., in Stevensville.

Why: The money will be used to purchase grocery and gas gift cards and distributed to families in need.

 

...

 
Vitamin E May Protect Against Kidney Cancer - Renal and Urology News - Renal and Urology News PDF Print
July 07, 2015 Vitamin E May Protect Against Kidney Cancer - Renal and Urology News - Renal and Urology News
High dietary intake of this antioxidant decreased the risk of renal cell carcinoma, according to a recent meta-analysis.

Higher dietary intake of vitamin E may decrease the risk of renal cell carcinoma (RCC), new findings suggest.

In a meta-analysis of 7 case-control studies involving 5,789 cases and 14,866 controls, Yonggang Shang, MD, and colleagues at the Third Military Medical University in Chongquing, China, found that, overall, the highest dietary intake of vitamin E was associated with a significant 25% decreased risk of RCC compared with the lowest intake. 

In European populations, the highest dietary intake of vitamin E was associated with a significant 42% decreased risk of RCC, the investigators reported in the Journal of Renal Nutrition (2015;25:339-344). The researchers found no association between dietary vitamin E intake and RCC risk in North American populations. The significant inverse association between dietary vitamin E intake and RCC risk did not differ by gender.

The mechanisms by which vitamin E impacts cancer risk are unknown, but vitamin E is a well known antioxidant that has been reported to inhibit tissue lipid peroxidation, apoptosis, 8-hydroxydeoxyguanosine formation, and cancer development, the authors pointed out. In addition, it plays an important role in protecting DNA from fragmentation.

...

 
<< Start < Prev 111 112 113 114 115 116 117 118 119 120 Next > End >>

Page 113 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.